LX-103(linxcell)

N/A

Report date: 2024/04/12 16:24:36

Base Information

Drug NameLX-103(linxcell)
Drug Alias NameLX-103(linxcell)LX103(linxcell)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Lingxin Borui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Lingxin Borui Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A